Why Some People Need More Protein, More Fat, or More Carbs — and It’s Written in Their Genes

The protein recommendation that appears on nutrition labels — about 50 grams per day for an average adult — is a population floor, not a personal prescription. It represents the amount estimated to prevent deficiency in most people under ordinary circumstances. What it doesn’t account for is how efficiently any individual person actually converts dietary protein into the amino acids their cells need, or how well those amino acids get transported into tissues, or how much is consumed by metabolic processes running faster than average because of genetic variants affecting detoxification, oxidative stress, or neurotransmitter clearance.

Protein is made of amino acids, and amino acids are made of protein — but the relationship between what you eat and what your cells actually have to work with is not a straight line. It’s a chain of enzymatic conversions, transport mechanisms, and metabolic processes, each step controlled by genes with known variants that can meaningfully slow or alter the process. A person can eat 150 grams of protein per day, have normal serum protein levels on a blood test, and still be functionally depleted in specific amino acids at the cellular level — because the bottleneck isn’t intake, it’s utilization.

This is the dimension of nutrition that standard dietary advice and even most functional medicine approaches rarely reach. The question isn’t just how much protein you eat. It’s whether your specific metabolic machinery can convert, transport, and deploy amino acids effectively — and that question has a genetic answer that’s increasingly measurable.

What Amino Acids Actually Do in the Body

There are twenty standard amino acids, nine of which are considered essential because the human body cannot synthesize them and must obtain them from food. These nine — histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine — form the raw material for an enormous range of biological functions that go far beyond building muscle.

Tryptophan is the sole dietary precursor to serotonin, which regulates mood, sleep, and appetite, and to melatonin, which governs the sleep-wake cycle. Phenylalanine is the precursor to tyrosine, which is then converted into dopamine, norepinephrine, and adrenaline. Methionine is the precursor to S-adenosylmethionine, or SAM-e — the universal methyl donor that powers hundreds of biochemical reactions including DNA methylation, neurotransmitter synthesis, and hormone processing. Lysine is essential for collagen synthesis and immune function. Leucine, isoleucine, and valine — the branched-chain amino acids — are primary signals for muscle protein synthesis and mitochondrial repair after exercise.

When any of these amino acids is functionally unavailable — either because dietary intake is low or because the conversion and transport processes are genetically compromised — the downstream biological processes that depend on them are affected. The symptoms that follow are often diverse enough that no single specialist would think to connect them to amino acid metabolism: persistent fatigue, low mood, slow recovery, poor wound healing, impaired concentration, disrupted sleep, heightened stress sensitivity. These are the experiences of people whose amino acid systems are struggling, often without any abnormality showing on a standard blood panel.

MTHFR: The Amino Acid Conversion Bottleneck

MTHFR has appeared throughout this series in the contexts of folate metabolism, methylation, cardiovascular health, fertility, and detoxification. Its role in amino acid metabolism adds yet another layer that makes it arguably the most consequential gene in practical nutrition.

The specific amino acid connection involves methionine. MTHFR drives the conversion of homocysteine back into methionine — an essential amino acid that serves as the precursor to SAM-e. When MTHFR activity is reduced by the C677T or A1298C variants, this conversion slows. Homocysteine accumulates, and the methionine supply available for SAM-e production falls. Since SAM-e is used by more than 200 enzymatic reactions throughout the body — including reactions that synthesize serotonin, dopamine, and norepinephrine — a methionine bottleneck from impaired MTHFR function can produce a cascade of effects that are difficult to trace back to their source.

People with MTHFR variants who supplement with standard folic acid are compounding the problem rather than solving it, because folic acid requires the MTHFR enzyme to convert it into the active methylfolate the body uses. Methylfolate bypasses this step. When MTHFR variants are present, the appropriate intervention for amino acid metabolism support is methylfolate plus methylcobalamin — not increased dietary protein alone — because the bottleneck is in the conversion chemistry, not the raw material supply.

COMT: When Amino Acid Demands Run High

The COMT gene encodes an enzyme that clears catecholamine neurotransmitters — dopamine, norepinephrine, and adrenaline — by methylating them. This methylation process is amino acid-dependent: it draws on methionine-derived SAM-e as the methyl donor. When COMT is running continuously to manage high catecholamine levels, it consumes SAM-e at an elevated rate, pulling methyl groups away from other critical processes.

The Val158Met variant of COMT changes the enzyme’s speed. The Met/Met genotype produces a slow-clearing version; catecholamines linger longer, and the methylation load required to clear them increases. People with this variant frequently experience heightened stress sensitivity, anxiety, and difficulty down-regulating from high-arousal states. They also have chronically elevated demands for the amino acids that feed the methylation cycle — methionine, glycine, and taurine. If their MTHFR is also variant, these two genetic factors compound: both slow the production of SAM-e and increase its consumption simultaneously.

The practical implication is that slow COMT carriers often need higher total amino acid intake — particularly of glycine and taurine, which are calming amino acids that support parasympathetic nervous system function — rather than stimulating amino acids like tyrosine or phenylalanine, which feed the very catecholamine pathways that are already running hot. The form and type of amino acid matters as much as the total amount.

SOD2: Oxidative Stress and Elevated Mitochondrial Amino Acid Needs

Every time cells produce energy, mitochondria generate reactive oxygen species as a byproduct. The enzyme that neutralizes those species inside mitochondria is superoxide dismutase 2, encoded by SOD2. The Val16Ala variant of SOD2 reduces how efficiently the enzyme is transported into mitochondria, leaving cells with less antioxidant protection during periods of high metabolic activity.

When mitochondria sustain more oxidative damage than usual, cells must accelerate their repair processes — and those processes consume amino acids. Branched-chain amino acids (leucine, isoleucine, valine) are particularly critical here, as they are primary substrates for mitochondrial protein repair and muscle tissue recovery. People with SOD2 variants running active lifestyles or experiencing chronic physiological stress find that standard protein intake doesn’t adequately support their recovery requirements, because their mitochondria are consuming amino acids at a higher rate to manage ongoing oxidative damage.

This is why two people following the same training program and eating the same amount of protein can have significantly different recovery trajectories. The person with functional SOD2 clears oxidative damage efficiently; the person with the Val16Ala variant does not. Supporting this genotype with BCAAs, manganese (a cofactor for SOD2), and antioxidant-dense nutrition directly addresses the underlying mechanism rather than just adding more protein to an inefficient system.

VDR: The Vitamin D Gate on Amino Acid Transport

The VDR gene encodes the vitamin D receptor, and its connection to amino acid metabolism is less intuitive but well established. Vitamin D, acting through its receptor, regulates the expression of genes that encode amino acid transport proteins — the proteins that carry amino acids across cell membranes and into the intracellular space where they can be used.

VDR variants that reduce receptor sensitivity require higher circulating vitamin D levels to achieve adequate amino acid transporter activation. When vitamin D levels are within the conventional “normal” range but receptor sensitivity is genetically reduced, amino acid import into cells can be meaningfully compromised. A person with VDR variants may have adequate amino acids in their bloodstream and inadequate amino acid availability inside their cells — a functional deficiency that standard serum testing won’t reveal.

This explains a pattern that appears frequently in clinical practice: people with VDR variants supplementing with standard-dose vitamin D3 who report persistent fatigue, poor muscle recovery, and difficulty building strength despite adequate protein intake. The amino acid transport bottleneck remains because the receptor still isn’t sufficiently activated. Higher-dose vitamin D3 — taken alongside magnesium to activate the converting enzyme and vitamin K2 to manage calcium appropriately — is the targeted intervention, and it addresses the amino acid utilization problem indirectly but effectively.

FADS1 and HFE: Membrane Function and Oxygen Delivery

Two additional genes in the amino acid network affect how cells function in ways that directly modify how much protein and which amino acids people require. The FADS1 gene governs the conversion of dietary plant omega-3 fats into EPA and DHA — the long-chain fatty acids that are incorporated into cell membranes. Cell membranes built from adequate EPA and DHA are fluid and responsive; membranes lacking these fatty acids become more rigid and less permeable. Because amino acid transport proteins are embedded in cell membranes, membrane quality directly affects how efficiently amino acids move into cells. People with FADS1 variants who can’t convert plant omega-3s into EPA and DHA efficiently have stiffer cell membranes and less effective amino acid import across the board — a transport limitation that affects every cell type simultaneously.

The HFE gene governs iron metabolism. Variants in HFE alter how iron is absorbed from the intestine and how it’s distributed throughout the body. Iron is essential for oxygen transport through hemoglobin and for the mitochondrial enzyme complexes involved in energy production. When iron metabolism is disrupted by HFE variants — in either direction, toward iron overload or iron insufficiency — cellular oxygen delivery is compromised, and the efficiency with which cells utilize amino acids in energy-consuming processes like muscle repair and neurotransmitter synthesis falls accordingly. Amino acids that require active metabolic processes to incorporate are particularly affected when cellular oxygen and energy availability are suboptimal.

What This Means for Protein Intake and Supplementation Decisions

The genetics of amino acid metabolism reframes the question of how much protein a person needs. It’s not simply a matter of body weight and activity level — those factors determine baseline requirements, but genetic variants in MTHFR, COMT, SOD2, VDR, FADS1, and HFE all modify how efficiently that protein baseline is actually utilized. Someone with three or four of these variants may have functional amino acid needs that are substantially higher than general recommendations — not because the recommendations are wrong for the average person, but because their metabolic machinery is running at reduced efficiency in multiple places simultaneously.

Equally important is the form of supplementation. Standard protein powders, multi-vitamins with folic acid, and generic B-vitamin complexes are formulated for the population average. For people whose genetic variants mean they can’t convert folic acid to methylfolate, can’t effectively utilize beta-carotene as vitamin A, or can’t build EPA and DHA from plant omega-3 sources, these products don’t address the actual deficit — they work around a conversion step that isn’t impaired in their specific case while ignoring the one that is. Genetic testing makes it possible to identify the actual bottlenecks and target them directly with the specific forms and combinations that match the individual’s biology.

Understanding Your Amino Acid Genetics
The SelfDecode Amino Acids report analyzes the genetic variants that govern how your body processes, converts, transports, and utilizes essential amino acids — examining key genes including MTHFR, COMT, SOD2, VDR, FADS1, and HFE. It identifies the specific amino acid metabolism bottlenecks in your genetic profile and delivers personalized recommendations for dietary protein, targeted amino acid supplementation, and supportive nutrients — with guidance on which forms of supplements apply to your specific variants. Compatible with existing 23andMe and AncestryDNA raw data.